KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Deferred Taxes (2016 - 2025)

Opko Health's Deferred Taxes history spans 14 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Deferred Taxes changed N/A year-over-year to $1.9 million; the TTM value through Dec 2025 reached -$3.0 million, changed N/A, while the annual FY2025 figure was -$3.0 million, 120.12% down from the prior year.
  • Deferred Taxes reached $1.9 million in Q4 2025 per OPK's latest filing, down from $18.3 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $18.3 million in Q3 2025 to a low of -$39.9 million in Q3 2022.
  • Average Deferred Taxes over 5 years is -$3.5 million, with a median of -$101000.0 recorded in 2021.
  • Peak YoY movement for Deferred Taxes: soared 746.27% in 2021, then tumbled 39445.54% in 2022.
  • A 5-year view of Deferred Taxes shows it stood at $7.8 million in 2021, then crashed by 428.0% to -$25.5 million in 2022, then soared by 71.57% to -$7.3 million in 2023, then soared by 206.06% to $7.7 million in 2024, then crashed by 75.53% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Deferred Taxes are $1.9 million (Q4 2025), $18.3 million (Q3 2025), and -$15.7 million (Q2 2025).